CZEN-002

司来普伐肽

Report date: 2022/06/27 20:00:35
NME

Base Information

Drug NameCZEN-002
Drug Alias Name抗菌双肽ZK-004(CKPV)2CZEN-002MSH-11-13-Dimer
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsDermatitis, AtopicCandidiasisMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesAbiogen Pharma SpaZengen
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesZhaoke Pharmaceutical (Hefei) Co Ltd
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicCandidiasisMycoses

Other Information

ATC CodeN/A
Related LinksDrugBank